e8vk
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 2, 2009
NUVASIVE, INC.
(Exact name of registrant as specified in its charter)
         
Delaware   000-50744   33-0768598
(State or Other Jurisdiction of
Incorporation)
  (Commission File
Number)
  (I.R.S. Employer Idenitifcaiton
Number)
7475 Lusk Boulevard, San Diego, California 92121
(Address of principal executive offices, with zip code)
(858) 909-1800
(Registrant’s telephone number, including area code)
n/a
(Former name or former address, if changed since last report)
     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


TABLE OF CONTENTS

Item 5.02 Compensatory Arrangements with Certain Officers
SIGNATURES


Table of Contents

Item 5.02 Compensatory Arrangements with Certain Officers
On January 2, 2009, the Compensation Committee of the Board of Directors of NuVasive, Inc. (the “Company”) set annual base salaries for the Company’s executive officers for calendar year 2009, effective January 1, 2009, and determined the annual stock option grants for the Company’s executive officers, in accordance with the terms of the Company’s 2004 Equity Incentive Plan. In determining the annual base salaries, the Compensation Committee took into consideration that certain perquisites provided in 2008 and in previous years will no longer be offered to the executive officers. The base salaries and annual option grants for the Company’s named executive officers (as defined in Item 402(a)(3) of Regulation S-K) were established as follows:
                     
                2009 Option Grants
Name   Position   2009 Salary   (# of shares)
Alexis V. Lukianov
  Chairman and Chief Executive Officer   $ 800,000       400,000  
Keith C. Valentine
  President and Chief Operating Officer   $ 500,000       200,000  
Kevin C. O’Boyle
  Executive Vice President and Chief Financial Officer   $ 365,000       75,000  
Patrick Miles
  Executive Vice President, Marketing and Product Development   $ 375,000       150,000  
Jeffrey Rydin
  Senior Vice President, U.S. Sales   $ 350,000       100,000  

-2-


Table of Contents

SIGNATURES
          Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  NUVASIVE, INC.
 
 
Date: January 8, 2009  By:        /s/ Alexis V. Lukianov    
    Alexis V. Lukianov   
    Chairman and Chief Executive Officer   
 

-3-